Biotechnology News

July 29, 2014

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central...

July 29, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--23andMe has received from the NIH a grant totaling $1,367,504 for a two-year project to support the further development of 23andMe’s web-based database and research engine for genetic discovery.

July 29, 2014

MILAN--(BUSINESS WIRE)--Sorin Group gets U.S. FDA approval for Solo Smart, the first aortic valve with a removable stent that provides native-like performance with the ease of implant of a stented valve.

July 29, 2014

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jin-En International Group Holding Co. (“Jin-en” or “the Company”) (PINK.BB: JINZ), is pleased to announce the acquisition 100% of the outstanding shares of Nascent Biotech Inc., a Nevada corporation (“NBI...

July 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Abbie Celniker, Ph.D., President and CEO of Eleven Biotherapeutics, to present at the Wedbush 2014 Life Sciences Management Access Conference in NY on Tuesday, August 12, 2014 at 2:30 p.m. ET

July 29, 2014

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces date and time of Q2 2014 financial results reporting.

July 29, 2014

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq:NPSP) announced today that it will report its second 2014 financial results on Wednesday, August 6, 2014 at approximately 4:30 p.m. ET. The press release will be followed by a...

July 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it has added three new events to its series of online “RNAi Roundtables” that it is hosting during July and...

July 29, 2014

ATLANTA--(BUSINESS WIRE)--Amniox Medical, Inc., a developer and marketer of restorative therapies processed from amniotic membrane and umbilical cord, announces the initiation of a randomized, controlled clinical trial of its proprietary product...

July 29, 2014

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) announced today that U.S. District Judge Leonard P. Stark has established August 18th as the date for a patent claim construction hearing, also called a Markman hearing, involving Enzo Life...

July 29, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) today announced financial results for the fiscal year ended April 30, 2014, and provided a corporate update.

July 29, 2014

LA JOLLA, Calif.--(BUSINESS WIRE)--Intrinsic LifeSciences has been awarded a $4.45M grant from NIH to fund a study to clinically validate the Hepcidin Index test for the differential diagnosis of Iron Refractory Iron Deficiency Anemia

July 29, 2014

NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation (Nasdaq: OPHT) today announced that it will release its financial results for the second quarter ended June 30, 2014, on Wednesday, August 6, 2014.

July 29, 2014

SEATTLE & CHICAGO--(BUSINESS WIRE)--Nanostring has expanded the capabilities of its nCounter Elements™ General Purpose Reagents (GPRs) to offer specific detection and analysis of known fusion genes.

July 29, 2014

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX today confirmed its commitment to support the diagnostic market with the unveiling of the Triple Quad™ 4500MD and QTRAP® 4500MD LC/MS/MS systems under its SCIEX Diagnostics brand.

July 29, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen will host a conference call at 10:00 AM EDT on Tuesday, August 5, 2014 to review the second quarter 2014 results. Results will be on the Company’s website prior to the conference call.

July 29, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) reported financial results for second-quarter 2014. At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting...

July 29, 2014

SEATTLE & NEW YORK--(BUSINESS WIRE)--Accelerator Corporation Secures $51.1 Million to
Support Emerging Biotechnology Research Opportunities in New York City and Seattle

July 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ: FMI) today announced the launch of an updated FoundationOne®, incorporating several enhancements that reflect the company’s ongoing commitment to innovation in patient care....

July 29, 2014

PARIS--(BUSINESS WIRE)--Cellectis sells its Swedish subsidiary, Cellectis AB, to the Japanese company Takara Bio Inc.

July 29, 2014

TORONTO--(BUSINESS WIRE)--ANTIBE THERAPEUTICS REPORTS YEAR-END FINANCIAL AND OPERATING RESULTS

July 28, 2014

CHICAGO--(BUSINESS WIRE)--The 2014 American Association for Clinical Chemistry (AACC) today awarded Sony DADC BioSciences and Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC) with its Best Abstract of Interest to the Industry Division Award....

July 28, 2014

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company advancing NNR Therapeutics™, today announced top-line results from a Phase 2b clinical trial of TC-5214 as a treatment for overactive...

July 28, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced positive preliminary second quarter 2014 results and an update on its...

July 28, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced financial results for the second quarter ended June 30, 2014. "We...

July 28, 2014

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, LLC, bioMérieux’s molecular biology affiliate, today announced that it has recently signed a new purchasing agreement with HealthTrust to provide multi-target molecular diagnostics tests for...

July 28, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...

July 28, 2014

BEIJING--(BUSINESS WIRE)--CANbridge Life Sciences and EUSA Pharma, a subsidiary of Jazz Pharmaceuticals, have entered into a partnership to develop EUSA's Caphosol treatment in China for the treatment of chemo side effects.

July 28, 2014

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma and the United States Army announce the initiation of a clinical trial for the use of Theramine for the treatment of low back pain among active service members.

July 28, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--NERI certified for WBENC, NWBOC, and WOSB as small woman-owned business providing clinical trials and research services to pharmaceutical, medical device, and biotech industries.

July 28, 2014

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Henry Levy as executive vice president of client development and commercial services. Levy leads PPD’s customer-facing teams to...

July 28, 2014

SAN ANTONIO--(BUSINESS WIRE)--CelluTome™ Epidermal Harvesting System Makes Podiatry Today’s Top 10 New Innovation List

July 28, 2014

ZURICH--(BUSINESS WIRE)--Redbiotec, specializing in vaccine development, has successfully applied its unique expertise and innovative technology platform to complete a collaborative program with GE Healthcare Life Sciences.

July 28, 2014

NORWELL, Mass.--(BUSINESS WIRE)--Prolonged bed rest due to stroke, traumatic brain injury or spinal cord injury can cause adverse effects such as cardiovascular, respiratory and musculoskeletal deconditioning. It also increases the risk of...

July 28, 2014

PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--The Vaccine & Gene Therapy Institute of Florida (VGTI Florida®), has filed a new patent application covering an invention that includes potent anti-viral compounds.

July 28, 2014

WASHINGTON--(BUSINESS WIRE)--Published today in Applied Optics, a new wearable device may detect a common diabetes complication--called diabetic autonomic neuropathy--sooner, leading to better treatment outcomes.

July 28, 2014

OXFORD, England--(BUSINESS WIRE)--CN Bio Innovations announced today that it has signed a research agreement with Imperial to advance the development of in vitro models of liver infection based on the company’s LiverChip™ platform.

July 28, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at investor conferences during August 2013. On Wednesday,...

July 28, 2014

CAMBRIDGE, Mass. & BRUSSELS--(BUSINESS WIRE)--Technology company MC10 Inc. and global biopharmaceutical company UCB announced that they have entered into a partnership to develop MC10’s Biostamp™ platform for patient-focused disease...

July 28, 2014

SAN FRANCISCO & RALEIGH-DURHAM, N.C.--(BUSINESS WIRE)--Cytonet announced today that new research on its investigational liver cell therapy (LCT) was presented on July 27, 2014 at the 2014 World Transplant Congress (WTC) in San Francisco. The...

July 28, 2014

CHICAGO--(BUSINESS WIRE)--Thermo Fisher Scientific today highlighted its expanded portfolio of instruments, equipment, consumables and software for improving accuracy and efficiency in the clinical laboratory at AACC 2014.

July 28, 2014

BROOKLINE, Mass.--(BUSINESS WIRE)--The studies lay the groundwork for tests that use genomic markers as part of a surveillance program to detect and respond to early signs of graft injury. Tests will be available through a CLIA lab.

July 28, 2014

CHICAGO--(BUSINESS WIRE)--Thermo Fisher Scientific has unveiled three Class-1 Medical Devices for use as components of laboratory-developed tests for analyzing patient samples: a mass spec, liquid chromatograph and software.

July 28, 2014

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics IVD, a market leader for in vitro diagnostic assay components, is introducing StabilZyme® Protein-Free AP Stabilizer at the American Association for Clinical Chemistry meeting in Chicago.

July 28, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it will host a conference...